The Vianex Group has entered into a strategic cooperation with Invicta Commercial Ltd., which is active in the marketing of medical consumables and medical devices, serving professionals and businesses in the health sector.

In this context, Vianex Group acquires a majority stake in the share capital of Invicta, thus aiming to develop the services provided and promote best practices in the healthcare sector, according to an official announcement.

Invicta Commercial S.A. is a dynamically growing company, specializing in the marketing of medical consumables and healthcare products, while its partner base includes professionals and pharmacies in Greece and Cyprus. Through significant partnerships, quality certifications and investments in technology, it offers innovative solutions, having established its position as a reliable partner in the healthcare sector.

The new strategic partnership is part of Vianex Group's broader business plan to expand its product and service portfolio. With a focus on people and a key focus on providing excellent service to patients and healthcare professionals, Vianex Group aims to continuously provide innovative solutions that improve the quality of life, while strengthening the Greek society and economy.

Mr. Dimitris Giannakopoulos, Chairman of the Board & CEO of Vianex Group, noted regarding the new strategic partnership with Invicta:

"Having already counted a century in the pharmaceutical sector, for us at Vianex Group, it is a key business objective to seek new opportunities for cooperation in order to serve both the medical community and patients. Through our new strategic partnership with INVICTA, a company that offers products that cover different medical specialties and needs, while investing in new technologies, we are given the opportunity to jointly offer new products and services to improve quality in the daily lives of patients and our customers".